- Type / Class
- Equity / Class A Stock
- Shares outstanding
- 115,244,363
- Total 13F shares
- 112,764,178
- Share change
- -599,787
- Total reported value
- $7,722,959,830
- Put/Call ratio
- 21%
- Price per share
- $68.49
- Number of holders
- 443
- Value change
- -$3,143,182
- Number of buys
- 196
- Number of sells
- 220
Quarterly Holders Quick Answers
What is CUSIP 379577208?
CUSIP 379577208 identifies GMED - GLOBUS MEDICAL INC - Class A Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 379577208:
Top shareholders of GMED - GLOBUS MEDICAL INC - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9.5%
|
10,954,681
|
$587,609,089 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.4%
|
10,883,358
|
$583,783,324 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
6.6%
|
7,662,395
|
$411,010,868 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
3,577,616
|
$191,903,322 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.8%
|
3,249,808
|
$174,319,701 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
2.6%
|
3,016,702
|
$161,815,923 | — | 31 Mar 2024 | |
| Champlain Investment Partners, LLC |
13F
|
Company |
2.2%
|
2,504,383
|
$134,335,104 | — | 31 Mar 2024 | |
| Camber Capital Management LP |
13F
|
Company |
2.2%
|
2,500,000
|
$134,100,000 | — | 31 Mar 2024 | |
| Burgundy Asset Management Ltd. |
13F
|
Company |
2.2%
|
2,479,837
|
$133,018,457 | — | 31 Mar 2024 | |
| HAWK RIDGE CAPITAL MANAGEMENT LP |
13F
|
Company |
2.1%
|
2,366,841
|
$126,957,351 | — | 31 Mar 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
2,236,914
|
$119,988,067 | — | 31 Mar 2024 | |
| Sculptor Capital LP |
13F
|
Company |
1.9%
|
2,210,738
|
$118,583,986 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.8%
|
2,112,103
|
$113,293,239 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
1.7%
|
1,949,213
|
$104,555,785 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,888,991
|
$101,345,522 | — | 31 Mar 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.5%
|
1,746,653
|
$93,690,000 | — | 31 Mar 2024 | |
| Magnetar Financial LLC |
13F
|
Company |
1.5%
|
1,689,287
|
$90,613,355 | — | 31 Mar 2024 | |
| GENEVA CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,571,886
|
$84,315,954 | — | 31 Mar 2024 | |
| Van Berkom & Associates Inc. |
13F
|
Company |
1.3%
|
1,542,351
|
$82,732,000 | — | 31 Mar 2024 | |
| AXA S.A. |
13F
|
Company |
1.3%
|
1,470,799
|
$78,893,659 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
1,391,694
|
$74,650,466 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.1%
|
1,229,440
|
$65,947,161 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
1%
|
1,154,072
|
$61,904,422 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
1,151,660
|
$61,776,000 | — | 31 Mar 2024 | |
| PARADIGM CAPITAL MANAGEMENT INC/NY |
13F
|
Company |
0.88%
|
1,011,400
|
$54,251,496 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.87%
|
1,000,000
|
$53,640,000 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.85%
|
984,530
|
$52,810,189 | — | 31 Mar 2024 | |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. |
13F
|
Company |
0.84%
|
964,092
|
$51,714,000 | — | 31 Mar 2024 | |
| Global Alpha Capital Management Ltd. |
13F
|
Company |
0.81%
|
927,741
|
$49,764,027 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.72%
|
831,946
|
$44,626,000 | — | 31 Mar 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.7%
|
803,108
|
$43,078,713 | — | 31 Mar 2024 | |
| Boston Trust Walden Corp |
13F
|
Company |
0.65%
|
748,738
|
$40,162,306 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.64%
|
737,137
|
$39,540,028 | — | 31 Mar 2024 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
0.64%
|
733,071
|
$39,321,928 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.63%
|
730,975
|
$39,209,499 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.63%
|
727,196
|
$39,006,794 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.62%
|
715,984
|
$38,405,442 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.62%
|
713,315
|
$38,262,217 | — | 31 Mar 2024 | |
| Madison Avenue Partners, LP |
13F
|
Company |
0.61%
|
703,276
|
$37,723,725 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.6%
|
686,026
|
$36,798,000 | — | 31 Mar 2024 | |
| Grantham, Mayo, Van Otterloo & Co. LLC |
13F
|
Company |
0.58%
|
666,053
|
$35,727,083 | — | 31 Mar 2024 | |
| Paradice Investment Management LLC |
13F
|
Company |
0.56%
|
641,061
|
$34,386,512 | — | 31 Mar 2024 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.55%
|
633,641
|
$33,988,000 | — | 31 Mar 2024 | |
| Pembroke Management, LTD |
13F
|
Company |
0.54%
|
626,601
|
$33,610,878 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.52%
|
599,312
|
$32,147,096 | — | 31 Mar 2024 | |
| Bellevue Group AG |
13F
|
Company |
0.5%
|
579,898
|
$31,105,729 | — | 31 Mar 2024 | |
| Capital World Investors |
13F
|
Company |
0.5%
|
574,500
|
$30,816,180 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.5%
|
571,929
|
$30,678,271 | — | 31 Mar 2024 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.46%
|
529,825
|
$28,419,813 | — | 31 Mar 2024 | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ |
13F
|
Company |
0.44%
|
508,874
|
$27,296,001 | — | 31 Mar 2024 |
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2024
As of 30 Jun 2024,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
443 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
112,764,178 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, Bank of New York Mellon Corp, Burgundy Asset Management Ltd., Camber Capital Management LP, and Champlain Investment Partners, LLC.
This page lists
445
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
435
Q2 2024 holders
443
Holder diff
8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.